Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept.

Abstract

OBJECTIVE To analyse the effectiveness and safety of Infliximab in a group of patients with systemic juvenile idiopathic arthritis (SJIA) who had failed treatment with etanercept in a single paediatric rheumatology clinic. METHODS Patients with SJIA with active polyarthritis refractory to methotrexate (MTX) [> or = 20 mg/m2/week] for at least 3 months and… (More)

Topics

Cite this paper

@article{Katsicas2005UseOI, title={Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept.}, author={Mar{\'i}a Marta Katsicas and Riccardo Russo}, journal={Clinical and experimental rheumatology}, year={2005}, volume={23 4}, pages={545-8} }